Another case of use of the ProSeal TM laryngeal mask airway in a dif®cult obstetric airway EditorÐWe read with interest the case report by Awan and colleagues, 1 describing successful use of the ProSealÔ laryngeal mask airway (PLMA) after failed tracheal intubation in a parturient undergoing Caesarean section. After securing the airway with the PLMA, the authors removed it and tried again to perform tracheal intubation. We think that the PLMA can be left in place and used as a de®nitive airway after failed intubation in Caesarean section. We report another case where the PLMA was used as an alternative to intubation and as a de®nitive airway throughout elective Caesarean section after failed tracheal intubation.
A 36-yr-old parturient, gravida 2, para 1, was scheduled for elective Caesarean section, on request, after a previous emergency Caesarean section. She was 168 cm tall and weighed 89 kg. Preoperative examination of the airway revealed a Mallampati score 2 of 1. After two failed attempts to perform spinal anaesthesia it was decided to perform general anaesthesia, upon the request of the patient. Rapid sequence induction (RSI) was performed after preoxygenation using thiopental 450 mg and succinylcholine 100 mg. After two failed attempts to perform tracheal intubation, using ®rst the Miller and then the Magill laryngoscope blade, a size 4 PLMA was introduced using the digital technique. A female infant with Apgar score 10 was delivered. The patient was satisfactorily ventilated and oxygenated (Sp O 2 99%, E¢ CO 2 38 mm Hg) and the PLMA was left in place throughout surgery, which lasted 25 min. No other attempts to perform tracheal intubation were made. A gastric tube (size 14) was passed though the gastric channel of the PLMA and 5 ml of gastric¯uid was aspirated. Neuromuscular block was achieved using atracurium 30 mg and analgesia provided with fentanyl 0.3 mg. At the end of surgery, the PLMA was removed when the patient was awake. Leaving the PLMA in place after securing the airway and using it as the de®nitive airway for the duration of anaesthesia is a reasonable alternative to the classic LMA in an unrecognized dif®cult obstetric airway. Unlike the classic LMA, the PLMA is capable of protecting the airway in the event of passive regurgitation intraoperatively by allowing regurgitated¯uid to pass up the drain tube and bypass the glottis. 3
S. J. Vaida L. A. Gaitini Haifa, Israel
EditorÐWe thank Drs Vaida and Gaitini for their interest in our case report. They describe use of the PLMA during an elective case. It is therefore likely that the patient had both been starved and given routine gastric prophylaxis preoperatively. It is not clear from their letter whether ventilation of the lungs was possible when tracheal intubation failed. We reported an emergency case where the dif®culty occurred both with tracheal intubation and with pulmonary ventilation (`can't intubate, can't ventilate' or CICV). 1 Vaida and Gaitini state that`leaving the PLMA in place¼ seems to be a reasonable alternative to the classic LMA in an unrecognized dif®cult obstetric airway'. There are two issues here; ®rst, which is the best rescue device, and second, how to proceed after the airway has been`rescued'? First, we entirely agree that in this circumstance the PLMA is a better choice than the cLMA. Regarding subsequent management, at present, rightly or wrongly, it is standard practice to use RSI for elective Caesarean section. While this is the case, an airway rescue device should be regarded as a device to enable oxygenation and ventilation until the patient can be woken. 4 5 If this was not the case, surely it would be logical to use the cLMA or PLMA in the ®rst place. In their case, therefore, standard practice would be to establish an airway and ventilation, then wake the patient before proceeding to ®breoptic intubation or further attempts at regional anaesthesia. A broader discussion might include the necessity for RSI in elective Caesarean section, 5 6 and the role of the PLMA would be central to this discussion.
Our clinical experience and the published evidence (clinical, anecdotal, laboratory-based and design-based) lead us to believe that the PLMA does provide greater protection against pulmonary aspiration of stomach contents than other`rescue' airways that might be used in the event of failed tracheal intubation. In due course, it may become recognized that the PLMA provides enough protection from pulmonary aspiration for it to become acceptable as a standard choice when tracheal intubation has failed during RSI, and for subsequent ventilation of the lungs (à silver standard' to the tracheal tube's`gold'). Vaida and Gaitini appear to tacitly assume that this state of affairs is with us, but we would caution that there is not enough evidence (nor consensus view) to regard this as safe practice, at present. Tracheostomy in a patient with SARS EditorÐI read this case report 1 with interest, and found myself somewhat confused by the information presented. Many of us will have followed the outbreak of severe acute respiratory syndrome (SARS) with interest and had serious concerns about the processes of infection control that were raised. I therefore found a number of the statements made in this case report to be out of keeping with the management principles that have been discussed in many places in the medical literature. First, in the discussion section, the authors state, in line with currently accepted knowledge, that a coronavirus is the likely primary infective agent in this disease. In the case report section, they discuss how they administered a number of antiviral agents, antibiotics and steroids. One cannot criticise this aspect of care, as at the time nobody knew exactly what they were treating. However, in the discussion section, they state that the main treatment for SARS consists of antibacterial agents, ribavirin and methylprednisolone. None of these agents has been shown to be of any bene®t in treating this infection. Antibacterial agents should be reserved for proven secondary bacterial infection, ribavirin has no activity against coronavirus, and methylprednisolone only augments the risk of secondary infection. The mainstay of treatment until a suitable anticoronavirus drug is developed is therefore supportive.
Later they go on to state that non-invasive ventilation may become necessary for treating respiratory failure. However, they then state that aerosol-generating procedures may facilitate transmission of the virus. Non-invasive ventilation is therefore surely contraindicated.
Finally, I am somewhat bemused at their decision to transport this potentially highly infectious patient from his ICU bed to an operating theatre for his tracheostomy to be performed. Was this patient nursed in a negative-pressure cubicle in the ICU? If so, why take the risk of moving him out of his room to the operating theatre to perform a procedure that could just as easily have been carried out at the bedside? Whether this patient could have successfully undergone percutaneous tracheostomy is not clear from the case report, but there are no contraindications given. Failing them, it is a perfectly acceptable technique to perform a surgical tracheostomy at the bedside, thus obviating the need to move the patient. Providing the same vigour is applied to infection control, as they outline in the discussion, there should be no greater risk from a percutaneous procedure than a surgical procedure. If anything, one might reasonably expect less risk as there is less bleeding and a much smaller incision using a percutaneous technique, and the operative time can be 5 min or less in skilled hands.
P. Morgan Cardiff, UK
EditorÐWe are grateful to Dr Morgan for his interest in our case report, 1 and in particular for raising questions on the treatment of SARS and the use of percutaneous trachesotomy.
At the time, when little was known regarding the best treatment for SARS, our patient received antiviral agents, antibiotics and steroids for his illness. With experience and more updated knowledge on the treatment of SARS, it now seems that the mainstay of treatment, as suggested by Dr Morgan, is supportive. 2 Non-invasive positive pressure ventilation has been used for treatment with some success in a small number of SARS patients with respiratory failure. 3 However, the therapy should be carried out only if the patient is nursed in an isolated room with negative pressure, and the attending health care workers are adequately protected with personal protective equipment (gown, boots, gloves, cap, N95-100 face mask, eye shield or goggles, and/or Airmate).
The reason to take the patient to the operating theatre for surgical tracheostomy is that, at the time the operation was performed, our ICU had no negative pressure cubicle. Subsequently, negative pressure rooms were constructed in our ICU for care of patients of high infectious risk. Although percutaneous tracheostomy was an option, our intensivists, who were physicians, were not experienced in the procedure. After lengthy discussion among surgeons, intensivists, and anaesthetists, it was decided that a surgical tracheostomy was a more familiar procedure to us and it was best performed in our familiar operating theatre environment. We cannot agree more that transport poses signi®cant risk to patients and staff, but we were more comfortable with our negative pressure operating theatre where support was easily available. Some patients in other intensive care units in Hong Kong did have percutaneous instead of surgical tracheostomies performed. The negative pressure rooms in those ICUs are small and noisy. Together with the extremely bulky personal protective equipment and restricted vision from the goggles and/or face shield, this seemingly simple procedure may be more dif®cult and time consuming than anticipated. 
